Wockhardt shares jumped more than 19 percent on Monday after the company received USFDA approval for its novel antibiotic ...
Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This marks a significant milestone as it is the first ...
Zaynich (cefepime and zidebactam) is an injectable antibiotic comprising cefepime, a cephalosporin antibacterial drug and ...
13h
Dabur shares fall 4% even as FMCG firm says engaging with US FDA over observations at Silvassa unit
Dabur shares fell over 4 percent after USFDA observations. USFDA flagged lapses at Dabur’s Silvassa plant in January. Dabur: ...
Hyderabad: Shilpa Medicare Limited has announced that the United States Food and Drug Administration (USFDA) conducted a ...
The approved tablets are bioequivalent to Sutab Tablets, the reference listed drug (RLD) of Azurity Pharmaceuticals.
The USFDA approved Wockhardt's antibiotic WCK 5222, marketed under the brand name Zaynich, for the treatment of complicated ...
The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed ...
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as Zydus) has received final approval from the United States Food and Drug ...
New Delhi: Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic medication for seizures. The company has received approval from the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results